J. Enloe
Director/Board Member presso BIOCOM
Patrimonio netto: - $ in data 31/03/2024
Profilo
J.
David Enloe was the founder of Lonza Houston, Inc. (founded in 1995) where he held the title of President & Chief Executive Officer from 1995 to 2013.
He is currently the Director at BIOCOM since 2018 and also holds the position of Director at Virocell Biologics Ltd.
Mr. Enloe's former positions include President & Chief Executive Officer at Ajinomoto Althea, Inc. from 2013 to 2020, President & Chief Executive Officer at Ajinomoto Bio-Pharma Services from 2018 to 2020, President, Chief Executive Officer & Director at Societal CDMO, Inc. from 2020 to 2024.
He also served as a Director at Terapio Corp.
and held the position of Region General Manager-Southeast Asia at Baker Hughes Holdings LLC from 1989 to 1995.
Additionally, Mr. Enloe was the Senior Vice President-Operations at Introgen Therapeutics, Inc. from 1995 to 2010 and worked as an Accountant at Arthur Andersen LLP.
He obtained his undergraduate degree from The University of Texas at Austin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SOCIETAL CDMO, INC.
-.--% | 08/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di J. Enloe
Società | Posizione | Inizio |
---|---|---|
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 19/02/2018 |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Director/Board Member | - |
Precedenti posizioni note di J. Enloe
Società | Posizione | Fine |
---|---|---|
SOCIETAL CDMO, INC. | Chief Executive Officer | 08/04/2024 |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/12/2020 |
Baker Hughes Holdings LLC
Baker Hughes Holdings LLC Wholesale DistributorsDistribution Services Baker Hughes Holdings LLC supplies oilfield services, products, technology, and systems to the worldwide oil and natural gas industry. It provides products and services for other businesses including downstream chemicals, and process and pipeline services. The company is headquartered in Houston, TX. | Corporate Officer/Principal | 01/01/1995 |
INTROGEN THERPUT | Chief Executive Officer | - |
Formazione di J. Enloe
The University of Texas at Austin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SOCIETAL CDMO, INC. | Health Technology |
Aziende private | 7 |
---|---|
Baker Hughes Holdings LLC
Baker Hughes Holdings LLC Wholesale DistributorsDistribution Services Baker Hughes Holdings LLC supplies oilfield services, products, technology, and systems to the worldwide oil and natural gas industry. It provides products and services for other businesses including downstream chemicals, and process and pipeline services. The company is headquartered in Houston, TX. | Distribution Services |
Introgen Therapeutics, Inc.
Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Terapio Corp.
Terapio Corp. Pharmaceuticals: MajorHealth Technology Terapio Corp. develops therapeutics based on the RLIP76 protein. The firm’s products are used in the areas of radiation countermeasure, chemical countermeasure and oncology supportive care. The company was founded by Casey Cunningham, Kevin Lalande and Sanjay Awasthi in 2005 and is headquartered in Austin, TX. | Health Technology |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- J. Enloe